Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis

Takashi Kajitani, Tetsuo Maruyama, Hironori Asada, Hiroshi Uchida, Hideyuki Oda, Sayaka Uchida, Kaoru Miyazaki, Toru Arase, Masanori Ono, Yasunori Yoshimura

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Nerve growth factor (NGF) has been recently proposed as one of the key factors responsible not only for promotion of nerve fiber growth but also for the onset and maintenance of pain in a variety of diseases. The aim of this study was to investigate the role of NGF in the pelvic pain associated with endometriosis. Tissue and peritoneal fluid samples were collected from 95 women with laparoscopically and histopathologically confirmed endometriosis and 59 control women without endometriosis. Expression levels of NGF mRNA and protein were examined using real-time RTPCR and immunohistochemistry, respectively. Concentration of NGF in the peritoneal fluid (PF-NGF) was measured using ELISA. The degree of dyspareunia and dysmenorrhea was evaluated using a verbal rating scale. Real-time RT-PCR analysis revealed that NGF mRNA was significantly more abundant in the ovarian endometriomas and peritoneal endometriosis than in the normal control endometrium. Immunohistochemical analyses demonstrated that NGF was prominently expressed and preferentially localized to the glands of the ovarian endometriomas and peritoneal endometriosis, whereas it was only weakly detectable in the normal endometrium. Although PF-NGF was undetectable in some normal subjects and endometriosis patients, elevated PF-NGF in the peritoneal fluid was more frequently observed in endometriosis patients with severe pain than in those with less severe pain. Our results suggest that NGF produced locally in the peritoneal cavity may be involved in the generation of endometriosis-associated pelvic pain.

Original languageEnglish
Pages (from-to)1155-1164
Number of pages10
JournalEndocrine Journal
Volume60
Issue number10
DOIs
Publication statusPublished - 2013

Fingerprint

Dyspareunia
Dysmenorrhea
Nerve Growth Factor
Endometriosis
Ascitic Fluid
Pelvic Pain
Endometrium
Pain
Messenger RNA
Peritoneal Cavity
Nerve Fibers
Real-Time Polymerase Chain Reaction
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
Maintenance

Keywords

  • Dysmenorrhea
  • Dyspareunia
  • Endometriosis
  • Nerve growth factor

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. / Kajitani, Takashi; Maruyama, Tetsuo; Asada, Hironori; Uchida, Hiroshi; Oda, Hideyuki; Uchida, Sayaka; Miyazaki, Kaoru; Arase, Toru; Ono, Masanori; Yoshimura, Yasunori.

In: Endocrine Journal, Vol. 60, No. 10, 2013, p. 1155-1164.

Research output: Contribution to journalArticle

Kajitani, Takashi ; Maruyama, Tetsuo ; Asada, Hironori ; Uchida, Hiroshi ; Oda, Hideyuki ; Uchida, Sayaka ; Miyazaki, Kaoru ; Arase, Toru ; Ono, Masanori ; Yoshimura, Yasunori. / Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. In: Endocrine Journal. 2013 ; Vol. 60, No. 10. pp. 1155-1164.
@article{bac41dd087d7448f8e3bf7368da1bea5,
title = "Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis",
abstract = "Nerve growth factor (NGF) has been recently proposed as one of the key factors responsible not only for promotion of nerve fiber growth but also for the onset and maintenance of pain in a variety of diseases. The aim of this study was to investigate the role of NGF in the pelvic pain associated with endometriosis. Tissue and peritoneal fluid samples were collected from 95 women with laparoscopically and histopathologically confirmed endometriosis and 59 control women without endometriosis. Expression levels of NGF mRNA and protein were examined using real-time RTPCR and immunohistochemistry, respectively. Concentration of NGF in the peritoneal fluid (PF-NGF) was measured using ELISA. The degree of dyspareunia and dysmenorrhea was evaluated using a verbal rating scale. Real-time RT-PCR analysis revealed that NGF mRNA was significantly more abundant in the ovarian endometriomas and peritoneal endometriosis than in the normal control endometrium. Immunohistochemical analyses demonstrated that NGF was prominently expressed and preferentially localized to the glands of the ovarian endometriomas and peritoneal endometriosis, whereas it was only weakly detectable in the normal endometrium. Although PF-NGF was undetectable in some normal subjects and endometriosis patients, elevated PF-NGF in the peritoneal fluid was more frequently observed in endometriosis patients with severe pain than in those with less severe pain. Our results suggest that NGF produced locally in the peritoneal cavity may be involved in the generation of endometriosis-associated pelvic pain.",
keywords = "Dysmenorrhea, Dyspareunia, Endometriosis, Nerve growth factor",
author = "Takashi Kajitani and Tetsuo Maruyama and Hironori Asada and Hiroshi Uchida and Hideyuki Oda and Sayaka Uchida and Kaoru Miyazaki and Toru Arase and Masanori Ono and Yasunori Yoshimura",
year = "2013",
doi = "10.1507/endocrj.EJ13-0027",
language = "English",
volume = "60",
pages = "1155--1164",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis

AU - Kajitani, Takashi

AU - Maruyama, Tetsuo

AU - Asada, Hironori

AU - Uchida, Hiroshi

AU - Oda, Hideyuki

AU - Uchida, Sayaka

AU - Miyazaki, Kaoru

AU - Arase, Toru

AU - Ono, Masanori

AU - Yoshimura, Yasunori

PY - 2013

Y1 - 2013

N2 - Nerve growth factor (NGF) has been recently proposed as one of the key factors responsible not only for promotion of nerve fiber growth but also for the onset and maintenance of pain in a variety of diseases. The aim of this study was to investigate the role of NGF in the pelvic pain associated with endometriosis. Tissue and peritoneal fluid samples were collected from 95 women with laparoscopically and histopathologically confirmed endometriosis and 59 control women without endometriosis. Expression levels of NGF mRNA and protein were examined using real-time RTPCR and immunohistochemistry, respectively. Concentration of NGF in the peritoneal fluid (PF-NGF) was measured using ELISA. The degree of dyspareunia and dysmenorrhea was evaluated using a verbal rating scale. Real-time RT-PCR analysis revealed that NGF mRNA was significantly more abundant in the ovarian endometriomas and peritoneal endometriosis than in the normal control endometrium. Immunohistochemical analyses demonstrated that NGF was prominently expressed and preferentially localized to the glands of the ovarian endometriomas and peritoneal endometriosis, whereas it was only weakly detectable in the normal endometrium. Although PF-NGF was undetectable in some normal subjects and endometriosis patients, elevated PF-NGF in the peritoneal fluid was more frequently observed in endometriosis patients with severe pain than in those with less severe pain. Our results suggest that NGF produced locally in the peritoneal cavity may be involved in the generation of endometriosis-associated pelvic pain.

AB - Nerve growth factor (NGF) has been recently proposed as one of the key factors responsible not only for promotion of nerve fiber growth but also for the onset and maintenance of pain in a variety of diseases. The aim of this study was to investigate the role of NGF in the pelvic pain associated with endometriosis. Tissue and peritoneal fluid samples were collected from 95 women with laparoscopically and histopathologically confirmed endometriosis and 59 control women without endometriosis. Expression levels of NGF mRNA and protein were examined using real-time RTPCR and immunohistochemistry, respectively. Concentration of NGF in the peritoneal fluid (PF-NGF) was measured using ELISA. The degree of dyspareunia and dysmenorrhea was evaluated using a verbal rating scale. Real-time RT-PCR analysis revealed that NGF mRNA was significantly more abundant in the ovarian endometriomas and peritoneal endometriosis than in the normal control endometrium. Immunohistochemical analyses demonstrated that NGF was prominently expressed and preferentially localized to the glands of the ovarian endometriomas and peritoneal endometriosis, whereas it was only weakly detectable in the normal endometrium. Although PF-NGF was undetectable in some normal subjects and endometriosis patients, elevated PF-NGF in the peritoneal fluid was more frequently observed in endometriosis patients with severe pain than in those with less severe pain. Our results suggest that NGF produced locally in the peritoneal cavity may be involved in the generation of endometriosis-associated pelvic pain.

KW - Dysmenorrhea

KW - Dyspareunia

KW - Endometriosis

KW - Nerve growth factor

UR - http://www.scopus.com/inward/record.url?scp=84887014599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887014599&partnerID=8YFLogxK

U2 - 10.1507/endocrj.EJ13-0027

DO - 10.1507/endocrj.EJ13-0027

M3 - Article

VL - 60

SP - 1155

EP - 1164

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 10

ER -